| 25/21/25 | NattoPharma ASA : - Delisting | AQ |
| 15/21/15 | NattoPharma : Received application for delisting | AQ |
| 14/21/14 | NattoPharma : Annual General Meeting in NattoPharma ASA | AQ |
| 10/21/10 | NattoPharma : OSLO BØRS - SUSPENDED | AQ |
| 09/21/09 | NattoPharma ASA: Compagnie des Levures Lesaffre announces compulsory acquisition | AQ |
| 1 day | +2.35% |
| Manager | Title | Age | Since |
|---|---|---|---|
Kjetil Ramsøy
CEO | Chief Executive Officer | 54 | 08/02/2018 |
Robert Schrama
DFI | Director of Finance/CFO | - | 09/03/2020 |
Gunilla Traberg
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Frode Marc Bohan
CHM | Chairman | 58 | 04/11/2004 |
| Director/Board Member | 52 | 01/02/2011 | |
Kjetil Ramsøy
BRD | Director/Board Member | 54 | 01/01/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.35% | +1.46% | - | - | 8.62Cr | |
| +0.35% | +1.98% | +48.69% | +140.47% | 1,27600Cr | |
| -0.13% | +5.35% | +48.83% | +90.43% | 68TCr | |
| +0.37% | +3.14% | +34.87% | +112.84% | 52TCr | |
| +0.02% | +2.79% | +44.10% | +69.76% | 39TCr | |
| -0.59% | +1.73% | +69.66% | +45.16% | 36TCr | |
| -1.29% | +0.94% | +29.88% | +58.29% | 31TCr | |
| +0.09% | +0.99% | +5.87% | +37.72% | 29TCr | |
| +0.62% | +1.49% | +44.63% | +75.12% | 25TCr | |
| -0.67% | +1.35% | +43.66% | +123.56% | 21TCr | |
| Average | +0.17% | +2.34% | +41.13% | +83.71% | 48TCr | |
| Weighted average by Cap. | +0.08% | +2.51% | +43.70% | +97.22% |
Employees
18
Sector
Pharmaceuticals
